Hospira wins UK case to overturn patents on Roche drug Herceptin

April 10, 2014 3:05 PM

9 0

Hospira wins UK case to overturn patents on Roche drug Herceptin

LONDON (Reuters) - Hospira has successfully overturned two patents on Roche's top-selling breast cancer drug Herceptin in Britain, clearing the way for it to launch a cheaper copycat version in the country.

A ruling handed down by the High Court in London on Thursday determined that both the 115 patent and the 455 patent on the drug were invalid.

Read more

To category page

Loading...